Related Experiment Video
Updated: Jul 17, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Paediatric Hepatology Dependency score (PHD score): an audit tool
Andrew D Cowley1, Carole Cummins, Sue V Beath
1The Liver Unit, The Institute of Child Health, Birmingham Children's Hospital, Birmingham, UK. cowleyandrew@o2.co.uk
Insights
A new Paediatric Hepatology Dependency score accurately measures disease severity in children with liver disease. This validated tool aids in patient assessment and hospital admission auditing.
Area of Science:
- Pediatric Hepatology
- Clinical Assessment Tools
- Disease Severity Measurement
Background:
- Developing a reliable tool to assess patient dependency and disease severity in pediatric liver disease is crucial.
- Existing methods may not adequately capture the spectrum of illness in children with mild to severe liver conditions.
Purpose of the Study:
- To develop and validate a novel scoring system for measuring patient dependency and disease severity in pediatric liver disease.
- To create a tool that is convenient and applicable to a heterogeneous group of pediatric patients with liver conditions.
Main Methods:
- A 10-parameter score was developed, incorporating markers like liver enzymes, albumin, bilirubin, ascites, nutritional support, organ dysfunction, blood product use, sepsis, and IV access.
- The score underwent rigorous statistical validation, including assessments of face validity, internal consistency (Cronbach's alpha), interobserver agreement, and construct validity.
- The score's predictive value was tested against endpoints such as survival and liver transplantation within 6 months.
Main Results:
- The final 10-variable Paediatric Hepatology Dependency score demonstrated good internal consistency (Cronbach's alpha = 0.72).
- The score effectively paralleled clinical deterioration and response to treatment.
- A score >15 significantly predicted death or transplantation (odds ratio 7, P=0.0125) and showed good agreement with the pediatric end-stage liver disease score (r=0.660, P<0.05).
Conclusions:
- The Paediatric Hepatology Dependency score is a valid, internally consistent, and practical tool for assessing disease severity in children with liver disease.
- This score facilitates auditing of hospital admissions and monitoring of patient progress.
- The tool is valuable for comparing patient cohorts across different time periods and interventions.
Background:
The aim was to develop a tool that measures patient dependency and disease severity in children with mild to severe liver disease.
Methods:
The initial pilot score was based on known markers of disease severity in acute and chronic liver disease. Between 1997 and 2001, the score was modified 4 times and reduced to comprise 10 key parameters: aspartate transaminase, prothrombin time, albumin, bilirubin, ascites, nutritional support, organ dysfunction, blood product support, sepsis and intravenous access. The score's face validity, internal consistency, interobserver agreement and construct validity were evaluated statistically and by the use of endpoints such as survival and transplant after 6 months.
Results:
The final 10 variable score was tested on 71 children admitted over two 3-month periods. The Cronbach's alpha score (a test for internal consistency) for the total score was 0.72. Serial data paralleled clinical deterioration and response to interventions. A Paediatric Hepatology Dependency score >15 had an odds ratio of 7 (P = 0.0125) for death or transplant at 6 months. The score was also found to agree with the paediatric end-stage liver disease score for the 12 patients being listed for liver transplantation (r = 0.660, P < 0.05).
Conclusion:
The Paediatric Hepatology Dependency score is valid and internally consistent and is a convenient measure of dependency and disease severity in a heterogeneous group of patients with liver disease. It also allows admissions to be audited for comparison between eras and for monitoring the progress of patients while on the ward.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

